Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression

(2010) Breno Satler Diniz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

(2009) C. Davatzikos et al.   BRAIN

Diagnostic transitions in mild cognitive impairment subtypes

(2009) Orestes Vicente Forlenza et al.   INTERNATIONAL PSYCHOGERIATRICS

Association Study of the Decreased Serum BDNF Concentrations in Amnestic Mild Cognitive Impairment and the Val66Met Polymorphism in Chinese Han

(2009) Hui Yu et al.   JOURNAL OF CLINICAL PSYCHIATRY

Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease

(2009) Paula Scalzo et al.   JOURNAL OF NEUROLOGY

Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients

(2009) Gislaine S. de Oliveira et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

(2009) Alan H Nagahara et al.   NATURE MEDICINE

Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects

(2009) Ge Li et al.   PLoS One

Mild cognitive impairment: cognitive screening or neuropsychological assessment?

(2009) Breno Satler Diniz et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

New insights into brain BDNF function in normal aging and Alzheimer disease

(2008) Lucia Tapia-Arancibia et al.   BRAIN RESEARCH REVIEWS

Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer’s disease

(2008) R. Hashimoto et al.   GENES BRAIN AND BEHAVIOR

Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia

(2008) Helton José Reis et al.   NEUROSCIENCE LETTERS

Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

(2008) Breno S. O. Diniz et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels

(2007) R. Christensen et al.   EXPERIMENTAL NEUROLOGY